VERICEL CORP
VCEL·92346J108·US·Common Stock·Healthcare - Biotechnology-13D/G
VCEL (VERICEL CORP) is held by 147 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($249.8M), STATE STREET CORP ($101.4M), VANGUARD CAPITAL MANAGEMENT LLC ($71.8M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 88 funds bought VCEL.
147
Holders
Avg rating(33 Elite)
$1.3B
Total Value
59% (159)
Fund Consensus
88 buying - 62 selling
Who's Trading
InsiderWKWotton Paul KSell $83KMay 11, 2026
InsiderMJMara Joseph Anthony JrSell $203KMay 7, 2026
InsiderSJSIEGAL JONATHANSell $58KMay 7, 2026
InsiderSJSIEGAL JONATHANSell $130KMay 6, 2026
ActivistSMSoleus Capital Master Fund, L.P.5.0%Apr 1, 2026
13F: Insider & Congress:
Showing 1-20 of 159
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer